AU2001262163A1 - Composition - Google Patents

Composition

Info

Publication number
AU2001262163A1
AU2001262163A1 AU2001262163A AU6216301A AU2001262163A1 AU 2001262163 A1 AU2001262163 A1 AU 2001262163A1 AU 2001262163 A AU2001262163 A AU 2001262163A AU 6216301 A AU6216301 A AU 6216301A AU 2001262163 A1 AU2001262163 A1 AU 2001262163A1
Authority
AU
Australia
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001262163A
Other languages
English (en)
Inventor
Philippe Hermand
Vincent Vande Velde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU2001262163A1 publication Critical patent/AU2001262163A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2001262163A 2000-10-12 2001-03-26 Composition Abandoned AU2001262163A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0025058.9A GB0025058D0 (en) 2000-10-12 2000-10-12 Composition
GB0025058 2000-10-12
PCT/EP2001/003786 WO2002030458A1 (fr) 2000-10-12 2001-03-26 Composition

Publications (1)

Publication Number Publication Date
AU2001262163A1 true AU2001262163A1 (en) 2002-04-22

Family

ID=9901176

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001262163A Abandoned AU2001262163A1 (en) 2000-10-12 2001-03-26 Composition

Country Status (5)

Country Link
AR (1) AR027738A1 (fr)
AU (1) AU2001262163A1 (fr)
CO (1) CO5270014A1 (fr)
GB (1) GB0025058D0 (fr)
WO (1) WO2002030458A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854803B1 (fr) * 2003-05-16 2005-06-24 Aventis Pasteur Composition vaccinale comprenant du phosphate de fer a titre d'adjuvent vaccinal.
JP2010502747A (ja) * 2006-09-08 2010-01-28 ベクトン・ディキンソン・アンド・カンパニー ミョウバン吸着ワクチンの安定粉末製剤
EP2034022A1 (fr) 2007-09-10 2009-03-11 Universite Libre De Bruxelles Récepteur de la lipocaline soluble liant le leukotriène B4 issu de Ixodes ricinus
EP2045263A1 (fr) 2007-10-02 2009-04-08 Universite Libre De Bruxelles Identification et caractérisation moléculaire de métalloprotéases salivaires exprimées dans les glandes salivaires de la tique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5239066A (en) * 1985-07-31 1993-08-24 The Board Of Trustees Of Leland Stanford Jr. University Yersinia ail nucleic acids
US5338842A (en) * 1985-07-31 1994-08-16 The Board Of Trustees Of Leland Stanford Jr. University Yersinia INV nucleic acids
WO2000018355A2 (fr) * 1998-09-30 2000-04-06 Walter Reed Army Institute Of Research Utilisation en tant que vaccin d'invaplex purifie obtenu a partir de bacteries a gram negatif
AU1227700A (en) * 1998-10-21 2000-05-08 St. Louis University Method for the production of purified invasin protein and use thereof

Also Published As

Publication number Publication date
WO2002030458A8 (fr) 2002-07-18
WO2002030458A1 (fr) 2002-04-18
CO5270014A1 (es) 2003-04-30
AR027738A1 (es) 2003-04-09
GB0025058D0 (en) 2000-11-29

Similar Documents

Publication Publication Date Title
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001258349A1 (en) Bisacylguanidine
AUPQ875700A0 (en) Combination compositions
AU2001279754A1 (en) Indoloquinazolinones
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001241098A1 (en) Composition
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001293852A1 (en) Sulfonylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU2001254731A1 (en) Substituted phenyluracils
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001281921A1 (en) Bdellosomes
AU2001275201A1 (en) Acne-treating composition
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU2001287852A1 (en) Composition
AU2001235764A1 (en) Compositions
AU2001287732A1 (en) Copolycarbonate-based composition